Connect with us


Anivive’s GC376 Reduces COVID-19 Replication, Shows Potential as New Post-Infection Treatment – PRNewswire

/PRNewswire/ — The Proceedings of the National Academy of Sciences, one of the world’s most cited and comprehensive scientific…

Article feature image

The PNAS article, “Postinfection treatment with a protease inhibitor increases survival of mice with a fatal SARS-CoV-2 infection,” details a study that shows mice with fatal SARS-CoV-2 infections experienced reduced viral load and improved survival when…

Click here to view the original article.

You might also like ...

Article feature image
Penn Medicine and Wistar secure $11.7 million SPORE grant for three melanoma research projects – News-Medical.Net
Article feature image
COVID-19 will become a seasonal disease, U-M epidemiologist says – News-Medical.Net